Identification of Gender-Specific Genetic Variants in Patients With Bicuspid Aortic Valve

Natasha Dargis1, Maxime Lamontagne1, Nathalie Gaudreault1

  • 1Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Quebec City, Quebec, Canada.

Insights

Genetic variants in the EGFR gene are associated with bicuspid aortic valve (BAV), a common congenital heart defect. This study also suggests gender-specific genetic factors may influence BAV development.

Area of Science:

  • Cardiovascular Genetics
  • Congenital Heart Disease
  • Genomics

Background:

  • Bicuspid aortic valve (BAV) is the most common congenital heart defect, affecting males disproportionately.
  • BAV often leads to serious valvular and aortic complications.
  • The genetic underpinnings of BAV remain largely unknown.

Purpose of the Study:

  • To identify genetic variants associated with BAV.
  • To investigate potential gender-specific genetic influences on BAV development.

Main Methods:

  • Sequencing of nine candidate genes in 48 BAV patients.
  • Evaluation of variant pathogenicity using the Combined Annotation Dependent Depletion (CAD) framework.
  • Genotyping of 89 variants in 323 BAV cases and 584 controls, with gender-stratified analyses.

Main Results:

  • Identified novel and potentially pathogenic variants, but none showed association with BAV in the case-control cohort.
  • Discovered a significant association between an intronic EGFR variant (rs17290301) and BAV.
  • Revealed distinct genetic variants associated with BAV in men (EGFR, TEX26) and women (NOTCH1, TGFBR2, NKX2-5).

Conclusions:

  • This study establishes the first association between EGFR genetic variants and BAV in humans.
  • Findings support a role for gender-specific genetic polymorphisms in BAV pathogenesis.
  • Further research into the genetic architecture of BAV is warranted.

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
89
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
863
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
425